Related references
Note: Only part of the references are listed.Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis
Austin M. Dulak et al.
CANCER RESEARCH (2012)
An integrated view of cyclin E function and regulation
Ka Tat Siu et al.
CELL CYCLE (2012)
Meta-analysis for cyclin E in lung cancer survival
Li-nian Huang et al.
CLINICA CHIMICA ACTA (2012)
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
Harry H. Yoon et al.
CLINICAL CANCER RESEARCH (2012)
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma
Yingchuan Hu et al.
MODERN PATHOLOGY (2011)
A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer
Irina Corin et al.
ACTA ONCOLOGICA (2010)
Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe
Fabrizio Galimberti et al.
CLINICAL CANCER RESEARCH (2010)
siRNA-Based Targeting of Cyclin E Overexpression Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in Breast Cancer Mouse Model
Yulong Liang et al.
PLOS ONE (2010)
Cell cyclins: triggering elements of cancer or not?
Michael Stamatakos et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2010)
Expression Levels of Cyclin G2, But Not Cyclin E, Correlate With Gastric Cancer Progression
Min-Gew Choi et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Differences in Protein Expression and Gene Amplification of Cyclins between Colon and Rectal Adenocarcinomas
Rolf Aamodt et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2009)
Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features
E. Ioachim
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas
Yan Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome
J Bondi et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
H Pohl et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Cyclin E deregulation alters the biologic properties of ovarian cancer cells
I Bedrosian et al.
ONCOGENE (2004)
Medical progress - Esophageal cancer
PC Enzinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma
R Cassia et al.
JOURNAL OF PATHOLOGY (2003)
Cyclin E and survival in patients with breast cancer.
K Keyomarsi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus
M Umansky et al.
ONCOGENE (2001)
Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma
JQ Li et al.
HUMAN PATHOLOGY (2001)
Share Paper
